Operating Risk (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sales Revenue, Net [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Concentration Risk [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Operating Risks | Details of customers accounting for 10% or more of total net sales for each of the three years ended March 31, 2023, 2024 and 2025 are as follows:
* Less than 10% |
||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Receivable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Concentration Risk [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Operating Risks | Debtors accounting for 10% or more of total accounts receivable at March 31, 2023 and 2024, respectively, are as follows:
* Less than 10% |